11 new epilepsy genes discovered

Thursday, 13 December, 2018

11 new epilepsy genes discovered

Epilepsy researchers from around the world examined the DNA of more than 45,000 people and have discovered 11 genes associated with the disorder.

Researchers led by University of Melbourne clinical neurologist Sam Berkovic compared the DNA of more than 15,000 people with epilepsy to the DNA of 30,000 control people without the disorder.

The results, published in Nature Communications, tripled the number of known genetic associations for epilepsy and — importantly — implicated 11 new genes which have a number of different functions in the human body. These include: regulating interactions between brain cells; converting vitamin-B6 into its active form, potentially making some forms of epilepsy easily treatable; how proteins are made from the blueprint of genes. 

The researchers found most available anti-epileptic drugs directly target one or more of these genes, but they also identified an additional 166 drugs that do the same. Professor Berkovic, who is based at Austin Health, said the discovery was significant because with current treatment options a third of the 65 million epilepsy patients worldwide cannot be effectively treated to be free of seizures.

“These drugs we’ve identified already exist but may show promise for treating epilepsy as they directly target the genetic basis of the disease,” Professor Berkovic said.

Professor Berkovic said epilepsy’s cause had long been shrouded in mystery. “We now understand that the cause is largely genetic, but little was known about the specific genes responsible for the most common forms of the disorder,” he said.

Professor Berkovic said more than 150 researchers from multiple centres in the UK, Europe, USA, Brazil, Hong Kong and Australia who are part of the International League Against Epilepsy Consortium on Complex Epilepsies took part in the study.

The next step would be replicating these results in an even larger sample, which is underway, and then drilling down on specific groups of patients and the genes that influence their type of epilepsy to trial new therapies, Professor Berkovic said.

Image credit: ©stock.adobe.com/au/ymgerma

Related News

New drug candidate for active rheumatoid arthritis

In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily...

Universal flu vaccine passes development milestones

Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the...

New regulator of immune responses identified

Scientists have discovered a new internal regulator that helps control the body's response to...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd